ANI Pharmaceuticals | ANIP - Trade Creditors


ANI Pharmaceuticals reported $62.58M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
ANI Pharmaceuticals USD 62.58M 7.21M Dec/2025
Assertio Holdings USD 14.66M 3.81M Sep/2025
Aurora Cannabis CAD 68.03M 18.68M Dec/2025
Canopy Growth CAD 19.96M 1.83M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Emergent BioSolutions USD 112.2M 500K Dec/2023
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Hikma Pharmaceutical USD 715M 104M Dec/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Perrigo USD 474.5M 4.8M Dec/2025
Sun Pharmaceuticals INR 67.06B 5.21B Sep/2025
Teva Pharmaceutical Industries USD 2.53B 176M Dec/2025